The U.S. 3D Bioprinting Market size was valued at around USD688 million in 2024 and is projected to reach USD1,887 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 17.88% during the forecast period, i.e., 2025-30. The main reason behind this growth is the high demand for developing drugs that have high efficacy and that too in the least possible time.
Natrad Autocare Geelong
Onschool Bootcamp
Stanley Robles
Molina Mclean
68win
Faulkner Duke
Bodel Conon
Arthur Ralston
Rode Sharpe
Wowturkey